493 Phase III comparison of telbivudine vs lamivudine in HBeAg-positive patients with chronic hepatitis B: Efficacy, safety, and predictors of response at 1 year

✍ Scribed by E. Gane; C.L. Lai; Y.E. Liaw; S. Thongsawat; Y. Wang; Y. Cheng; J. Heathcote; J. Rasenacks; N. Bzowej; N. Naoumov; G. Chao; B. Fielman; N. Brown

• Book ID: 117374770
• Publisher: Elsevier Science
• Year: 2006
• Tongue: English
• Weight: 244 KB
• Volume: 44
• Category: Article
• ISSN: 0168-8278
• DOI: 10.1016/s0168-8278(06)80493-9